Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
The Calpain Connection
19 May 2000. The cysteine protease calpain cleaves the cdk5 regulator p35, releasing a 25KD fragment that accumulates in the brains of people with Alzheimer’s disease. What’s more, Aβ42 is among the factors that trigger this reaction, report Li-Huei Tsai of Harvard Medical School and her coworkers in the May 18 Nature. These findings follow on the heels of Tsai’s recent study, which established p25’s role in tau hyperphosphorylation, cytoskeletal disruption, and apoptosis of cortical neurons (see news story below, 8 December, 1999). That study raised the question which conditions foster the fateful cleavage of p35 and which enzyme carries it out.

The present report answers these questions. Collaborating with Robert Friedlander, also of Harvard Medical School, Tsai first discovered that transient focal ischemia in mice induced p25 in the same side of the brain. (P25 has never been detected in healthy brain.) Then her group showed that free radicals, glutamate, and elevated intracellular calcium stimulate the conversion of p35 into p25 in cultured primary neurons. Inhibitors of the calcium-dependent protease calpain inhibited this reaction. Moreover, calpain cleaved p35 in brain lysates and, when assayed with purified p35, it generated a cleavage product whose sequence was identical to that of p25. Finally, the researchers found that Aβ42 leads to the generation of p25, and that calpain inhibitors rescued Aβ-induced neuronal death of cultured neurons.

Calpain has long been suspected to play a role in neurotoxicity. Randy Nixon, now at New York University, reported in 1997 that its activated form accumulated in neurofibrillary tangles, as well as pre-tangle structures, in neurons of people with AD.

Given that agents of neurotoxicity-glutamate overexcitation, hypoxic stress, and Aβ peptides-converge to alter calcium homeostasis in affected neurons, Tsai suggests that calpain’s conversion of p35 into p25 represents one mechanism by which these agents can lead to hyperphosphorylation of tau and cell death, thus contributing to Alzheimer’s pathology. This mechanism represents an example for how cdk5-a kinase essential to proper brain development and adult function-can be corrupted into damaging neurons, the authors write.-Gabrielle Strobel.

Reference:Lee MS, Kwon YT, Li M, Peng J, Friedlander RM, Tsai LH. Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 2000 May 18;405(6784):360-4. Abstract

 
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad